Back to Top
Tefibazumab Biosimilar - Research Grade
$710.00 - $6,900.00
Tefibazumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
fibrin-binding surface epitope clumping factor A
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Clumping factor A is a fibrinogen-binding surface adhesin of Staphylococcus aureus and a virulence factor of interest in anti-infective research. The reagent here is a research-grade, unconjugated analog of tefibazumab, a recombinant monoclonal antibody targeting clumping factor A, for research use only. It is manufactured to in vivo standards with low endotoxin and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. Applications include adhesin-blockade functional assays, in vitro fibrinogen-binding screens, and in vivo models of staphylococcal infection. The reagent is intended to deliver consistent, reproducible performance for heavy-usage research workflows.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













